IMMY sõna Aspergillus Galactomannan Lateral Flow Assay recommended by the European Confederation of Medical Microbiology (ECMM) as a screening device in ventilated patients.

New sample collection kit enables convenient and safe collection, transportation and handling of pathogenic samples including COVID-19 and influenza

New Range of CE Certified Face Visors and Type II Masks with Introductory 10% Savings

Demystify chromogenic testing

New QuickGene Range for DNA & RNA Extraction- Now with Automated Option

Take Control and Save Time with Easy In-house Testing

Patented transport media manufactured by EKF Diagnostics can help to increase COVID-19 testing capacity

As demand for rapid testing continues to accelerate at an unprecedented level, our response to assisting testing on a global scale must be in place to support accurate, reliable and easy-to-use testing. The AbC-19™ COVID-19 antibody test developed by Abingdon Health and the UK-RTC, achieves 98.03% sensitivity and 99.5% specifically, will play an invaluable role in overcoming unpredicted rapid testing outcomes.Download the whitepaper to learn: How the body responds to SARS-CO...

Abingdon Health announces £1M Innovate UK funding for the development of a fully quantitative lateral flow Smartphone Reader

Abingdon Health and DCN Diagnostics have announced a commercial partnership to provide Abingdon Health’s proprietary AppDx Smartphone m-Health technology to DCN Diagnostics’ customer base.